1
|
Marcus B, Arenberg D, Lee J, Kleer C,
Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, et al:
Prognostic factors in oral cavity and oropharyngeal squamous cell
carcinoma. Cancer. 101:2779–2787. 2004. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chang KW, Liu CJ, Chu TH, Cheng HW, Hung
PS, Hu WY and Lin SC: Association between high miR-211 microRNA
expression and the poor prognosis of oral carcinoma. J Dent Res.
87:1063–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gao B, Gao K, Li L, Huang Z and Lin L:
miR-184 functions as an oncogenic regulator in hepatocellular
carcinoma (HCC). Biomed Pharmacother. 68:143–148. 2014. View Article : Google Scholar
|
7
|
Zhang C: Novel functions for small RNA
molecules. Curr Opin Mol Ther. 11:641–651. 2009.
|
8
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Eulalio A, Mano M, Dal Ferro M, Zentilin
L, Sinagra G, Zacchigna S and Giacca M: Functional screening
identifies miRNAs inducing cardiac regeneration. Nature.
492:376–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Swarbrick A, Woods SL, Shaw A,
Balakrishnan A, Phua Y, Nguyen A, Chanthery Y, Lim L, Ashton LJ,
Judson RL, et al: miR-380-5p represses p53 to control cellular
survival and is associated with poor outcome in MYCN-amplified
neuroblastoma. Nat Med. 16:1134–1140. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
He L, He X, Lowe SW and Hannon GJ:
microRNAs join the p53 network - another piece in the
tumour-suppression puzzle. Nat Rev Cancer. 7:819–822. 2007.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu X, Wang A, Heidbreder CE, Jiang L, Yu
J, Kolokythas A, Huang L, Dai Y and Zhou X: MicroRNA-24 targeting
RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS
Lett. 584:4115–4120. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jia LF, Wei SB, Gong K, Gan YH and Yu GY:
Prognostic implications of micoRNA miR-195 expression in human
tongue squamous cell carcinoma. PLoS One. 8:e566342013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Li J, Huang H, Sun L, Yang M, Pan C, Chen
W, Wu D, Lin Z, Zeng C, Yao Y, et al: miR-21 indicates poor
prognosis in tongue squamous cell carcinomas as an apoptosis
inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Welcker M and Clurman BE: FBW7 ubiquitin
ligase: A tumour suppressor at the crossroads of cell division,
growth and differentiation. Nat Rev Cancer. 8:83–93. 2008.
View Article : Google Scholar
|
18
|
Cheng Y and Li G: Role of the ubiquitin
ligase Fbw7 in cancer progression. Cancer Metastasis Rev. 31:75–87.
2012. View Article : Google Scholar
|
19
|
Brandt Y, Mitchell T, Wu Y and Hartley RS:
Developmental downregulation of Xenopus cyclin E is phosphorylation
and nuclear import dependent and is mediated by ubiquitination. Dev
Biol. 355:65–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Akhoondi S, Sun D, von der Lehr N,
Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D,
Marth C, et al: FBXW7/hCDC4 is a general tumor suppressor in human
cancer. Cancer Res. 67:9006–9012. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hagedorn M, Delugin M, Abraldes I, Allain
N, Belaud-Rotureau MA, Turmo M, Prigent C, Loiseau H, Bikfalvi A
and Javerzat S: FBXW7/hCDC4 controls glioma cell proliferation in
vitro and is a prognostic marker for survival in glioblastoma
patients. Cell Div. 2:92007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Bredel M, Bredel C, Juric D, Harsh GR,
Vogel H, Recht LD and Sikic BI: Functional network analysis reveals
extended glioma-genesis pathway maps and three novel
MYC-interacting genes in human gliomas. Cancer Res. 65:8679–8689.
2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Iwatsuki M, Mimori K, Ishii H, Yokobori T,
Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H, et al:
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer:
Clinical significance. Int J Cancer. 126:1828–1837. 2010.
|
24
|
Yokobori T, Mimori K, Iwatsuki M, Ishii H,
Onoyama I, Fukagawa T, Kuwano H, Nakayama KI and Mori M:
p53-Altered FBXW7 expression determines poor prognosis in gastric
cancer cases. Cancer Res. 69:3788–3794. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
26
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu R, Zhang H, Wang X, Zhou L, Li H, Deng
T, Qu Y, Duan J, Bai M, Ge S, et al: The miR-24-Bim pathway
promotes tumor growth and angiogenesis in pancreatic carcinoma.
Oncotarget. 6:43831–43842. 2015.PubMed/NCBI
|
28
|
Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS
and Chang KW: miR-24 up-regulation in oral carcinoma: Positive
association from clinical and in vitro analysis. Oral Oncol.
46:204–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zheng X, Li J, Peng C, Zhao J, Chi J, Meng
X, Yun X, Li D, Yu Y, Gao M, et al: MicroRNA-24 induces cisplatin
resistance by targeting PTEN in human tongue squamous cell
carcinoma. Oral Oncol. 51:998–1003. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Du WW, Fang L, Li M, Yang X, Liang Y, Peng
C, Qian W, O'Malley YQ, Askeland RW, Sugg SL, et al: MicroRNA
miR-24 enhances tumor invasion and metastasis by targeting PTPN9
and PTPRF to promote EGF signaling. J Cell Sci. 126:1440–1453.
2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chen L, Zhang A, Li Y, Zhang K, Han L, Du
W, Yan W, Li R, Wang Y, Wang K, et al: miR-24 regulates the
proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4
signaling. Cancer Lett. 329:174–180. 2013. View Article : Google Scholar
|
32
|
Zaidi SK, Dowdy CR, van Wijnen AJ, Lian
JB, Raza A, Stein JL, Croce CM and Stein GS: Altered Runx1
subnuclear targeting enhances myeloid cell proliferation and blocks
differentiation by activating a miR-24/MKP-7/MAPK network. Cancer
Res. 69:8249–8255. 2009. View Article : Google Scholar : PubMed/NCBI
|
33
|
Papadimitriou E, Vasilaki E, Vorvis C,
Iliopoulos D, Moustakas A, Kardassis D and Stournaras C:
Differential regulation of the two RhoA-specific GEF isoforms
Net1/Net1A by TGF-β and miR-24: Role in epithelial-to-mesenchymal
transition. Oncogene. 31:2862–2875. 2012. View Article : Google Scholar
|
34
|
Ma Y, She XG, Ming YZ and Wan QQ: miR-24
promotes the proliferation and invasion of HCC cells by targeting
SOX7. Tumour Biol. 35:10731–10736. 2014. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhao G, Liu L, Zhao T, Jin S, Jiang S, Cao
S, Han J, Xin Y, Dong Q, Liu X, et al: Upregulation of miR-24
promotes cell proliferation by targeting NAIF1 in non-small cell
lung cancer. Tumour Biol. 36:3693–3701. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Koepp DM, Schaefer LK, Ye X, Keyomarsi K,
Chu C, Harper JW and Elledge SJ: Phosphorylation-dependent
ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.
Science. 294:173–177. 2001. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wu G, Lyapina S, Das I, Li J, Gurney M,
Pauley A, Chui I, Deshaies RJ and Kitajewski J: SEL-10 is an
inhibitor of notch signaling that targets notch for
ubiquitin-mediated protein degradation. Mol Cell Biol.
21:7403–7415. 2001. View Article : Google Scholar : PubMed/NCBI
|
38
|
Inuzuka H, Shaik S, Onoyama I, Gao D,
Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al:
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for
ubiquitylation and destruction. Nature. 471:104–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Olive V1, Sabio E, Bennett MJ, De Jong CS,
Biton A, McGann JC, Greaney SK, Sodir NM, Zhou AY, Balakrishnan A,
et al: A component of the mir-17-92 polycistronic oncomir promotes
oncogene-dependent apoptosis. Elife. 2:e008222013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Wang L, Ye X, Liu Y, Wei W and Wang Z:
Aberrant regulation of FBW7 in cancer. Oncotarget. 5:2000–2015.
2014. View Article : Google Scholar : PubMed/NCBI
|
41
|
Gong J, Cui Z, Li L, Ma Q, Wang Q, Gao Y
and Sun H: MicroRNA-25 promotes gastric cancer proliferation,
invasion, and migration by directly targeting F-box and WD-40
domain protein 7, FBXW7. Tumour Biol. 36:7831–7840. 2015.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Reavie L, Buckley SM, Loizou E, Takeishi
S, Aranda-Orgilles B, Ndiaye-Lobry D, Abdel-Wahab O, Ibrahim S,
Nakayama KI and Aifantis I: Regulation of c-Myc ubiquitination
controls chronic myelogenous leukemia initiation and progression.
Cancer Cell. 23:362–375. 2013. View Article : Google Scholar : PubMed/NCBI
|
43
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012. View Article : Google Scholar :
|